Summary

The VNA & PACS market is projected to reach USD 8.57 billion by 2031 from USD 5.60 billion in 2026, at a CAGR of 8.9%. The VNA & PACS market is seeing an increase in demand due to the evolution in the delivery of healthcare services, in which providers need imaging platforms that help coordinate care in hospitals, clinics, and diagnostic facilities. The adoption of a data-centric healthcare model has increased the demand for imaging records, which would allow clinicians to gain access to patients’ medical history and help with diagnosis and treatment plans. In addition to this, there is a demand for outpatient imaging centers, which need cloud-based PACS and VNA systems to support their imaging processes. Also, the rise in the adoption of software as a service (SaaS) business models by vendors has influenced the strategies of providers who look for flexible options and less expensive total cost of ownership models. This demand is further supported by the recent mergers and acquisitions in the industry, such as Intelerad Medical Systems Incorporated (Canada) acquired by GE HealthCare (US) in March 2026.

https://mnmimg.marketsandmarkets.com/Images/vendor-neutral-archive-VNA-PACS-market2-img-overview.webp

“By product type, the VNA segment accounted for the largest share of the VNA & PACS market in 2025.”
By type of product, the VNA category will dominate the VNA & PACS market in 2025 since it provides healthcare institutions with the ability to centrally manage imaging data and ensure the sustainability of their IT infrastructure through interoperability among different systems. Through VNAs, healthcare providers can separate their data from their proprietary PACS and allow for easy information exchange without compromising system dependency issues. As stated by the Healthcare Information and Management Systems Society (2023), health facilities are shifting towards an enterprise imaging approach that stresses interoperable and vendor-neutral infrastructure to promote better patient care and improve the accessibility of their information. Similarly, according to the European Society of Radiology, long-term archiving of images and cross-enterprise data exchange have become fundamental in radiology practices today. Recent industry trends indicate that Hyland Software, Inc. (US) is developing its cloud-based VNA solution in 2025 to meet the demands of large-scale enterprises.
“By vendor type, the third-party vendor segment is expected to have the fastest growth during the forecast period.”
Based on vendor type, the VNA & PACS market is segmented into independent vendors and third-party vendors. The third-party vendor market is projected to experience the highest rate of growth during the forecasted period, mainly owing to the growing demand for interoperability among different healthcare IT environments. Third-party vendors are involved in offering solutions that ensure interoperability among PACS, VNA, EHR, and various other clinical software applications so that healthcare organizations are able to integrate all of their data while maintaining their current infrastructure. As stated in a study conducted by Radsource in January 2025, PACS interoperability helps healthcare institutions become more efficient in the workflow process and improve overall patient care by exchanging data with other health systems. A recent development that shows the importance of PACS interoperability involves the enhancement of interoperable data management solutions by BridgeHead Software Ltd. (UK) and PaxeraHealth Corp. (US).
“APAC will witness the highest growth rate during the forecast period.”
The VNA & PACS Market in the Asia Pacific region is witnessing robust growth due to increased spending on healthcare infrastructure, swift digitization of hospitals, and the escalating need for imaging diagnostics in a large number of patients. The governments in the region are aggressively implementing digital health strategies at the national level to facilitate better data exchange and accessibility. As per the report published by the World Health Organization (2021), nations in the Asia Pacific region are fast-tracking their digital health technology adoption to optimize the efficiency and delivery of services in health systems. Furthermore, the development of hospital chains and increased usage of electronic medical records are driving a high demand for comprehensive imaging data management systems. For example, FUJIFILM Holdings Corporation (Japan) is expanding its enterprise imaging solutions in Asia Pacific in 2025, whereas Canon Medical Systems Corporation (Japan) upgraded its imaging informatics offerings in 2025.
The breakdown of primary participants is as given below:
? By Company Type - Tier 1: 40%, Tier 2: 35%, and Tier 3: 25%
? By Designation - C-level: 42%, Director-level: 31%, and Others: 27%
? By Region - North America: 35%, Europe: 30%, Asia Pacific: 25%, Latin America: 6%, Middle East & Africa: 5%
Agfa-Gevaert Group (Belgium) and Canon Medical Systems Corporation (Japan) are some of the key players in the VNA PACS market.
? The study includes an in-depth competitive analysis of these key players in the VNA PACS market, with their company profiles, recent developments, and key market strategies.

Research Coverage
This research report categorizes the VNA & PACS Market by Product Type (VNA [Department VNA, Multi-Department VNA, Multi-Site VNA], PACS [Department PACS, Multi-Department PACS, Multi-Site PACS]) | VNA & PACS Market, by Modality (CT, Mammography, MRI, Ultrasound, X-Rays, PET) | VNA & PACS Market, by Deployment (On-Premise Deployment, Cloud-Based Deployment, Hybrid Deployment) | VNA & PACS Market, by Vendor Type (Independent Vendor, Third-Party Vendor) | VNA & PACS Market, by Application (Cardiology, Orthopedic, Oncology, Neurology, Obstetrics and Gynecology, Other Applications) | VNA & PACS Market, by End User (Hospitals & Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Other End Users) and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the VNA PACS market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; contracts, partnerships, agreements, new product & service launches, mergers & acquisitions, and recent developments associated with the VNA PACS market. Competitive analysis of upcoming startups in the VNA PACS market ecosystem is covered in this report.
Reasons to buy this report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the VNA & PACS market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights into the following pointers:
? Analysis of key drivers (Heightened investments in medical imaging technologies, Growing demand for streamlined healthcare data management solutions, Integration of PACS/VNA with electronic medical records) restraints (High initial investment for implementing VNA and PACS solutions, Lack of standardized protocols and interoperability frameworks) opportunities (InFavorable government initiatives for better penetration of Al in medical imaging, Increasing medical imaging procedures and large imaging data silos, Rapid uptake of big data in healthcare) challenges (Rising security concerns related to cloud-based image processing and analytics, Data security issues in healthcare settings) influencing the growth of the VNA PACS market
? Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the VNA & PACS Market
? Market Development: Comprehensive information about lucrative markets; the report analyses the VNA PACS market across varied regions.
? Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the VNA & PACS Market
? Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like FUJIFILM Holdings Corporation (Japan), GE HealthCare (US), Merative (US), Sectra AB (Sweden), Siemens Healthineers AG (Germany), BridgeHead Software Ltd. (UK), among others, in the VNA PACS market

ページTOPに戻る

Table of Contents

1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.3 STUDY SCOPE 30
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 30
1.3.2 INCLUSIONS AND EXCLUSIONS 31
1.3.3 YEARS CONSIDERED 32
1.4 CURRENCY CONSIDERED 32
1.5 STAKEHOLDERS 33
2 EXECUTIVE SUMMARY 34
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 34
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 35
2.3 DISRUPTIVE TRENDS SHAPING VNA & PACS MARKET 36
2.4 HIGH-GROWTH SEGMENTS 37
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 38
3 PREMIUM INSIGHTS 39
3.1 ATTRACTIVE OPPORTUNITIES FOR VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET 39
3.2 NORTH AMERICA VNA PACS MARKET, BY END USER AND COUNTRY 40
3.3 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY COUNTRY 41
4 MARKET OVERVIEW 42
4.1 INTRODUCTION 42
4.2 MARKET DYNAMICS 42
4.2.1 DRIVERS 43
4.2.1.1 Heightened investments in medical imaging technologies 43
4.2.1.2 Growing demand for streamlined healthcare data management solutions 43
4.2.1.3 Integration of PACS/VNA with Electronic Medical Records (EMRs) 44
4.2.2 RESTRAINTS 45
4.2.2.1 High initial investment 45
4.2.2.2 Lack of standardized protocols and interoperability frameworks 45
4.2.3 OPPORTUNITIES 46
4.2.3.1 Government initiatives to increase penetration of AI in medical imaging 46
4.2.3.2 Increasing medical imaging procedures and large imaging data silos 47
4.2.3.3 Rapid uptake of big data in healthcare 47
?
4.2.4 CHALLENGES 48
4.2.4.1 Rising security concerns related to cloud-based image processing and analytics 48
4.2.4.2 Data security issues 49
4.3 UNMET NEEDS AND WHITE SPACES 49
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 50
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 50
5 INDUSTRY TRENDS 52
5.1 PORTER’S FIVE FORCES ANALYSIS 52
5.1.1 INTENSITY OF COMPETITIVE RIVALRY 53
5.1.2 BARGAINING POWER OF SUPPLIERS 53
5.1.3 BARGAINING POWER OF BUYERS 53
5.1.4 THREAT OF NEW ENTRANTS 53
5.1.5 THREAT OF SUBSTITUTES 54
5.2 MACROECONOMICS INDICATORS 54
5.2.1 INTRODUCTION 54
5.2.2 GDP TRENDS AND FORECAST 54
5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY 54
5.3 VALUE CHAIN ANALYSIS 54
5.4 ECOSYSTEM MAPPING 56
5.5 PRICING ANALYSIS 59
5.5.1 AVERAGE SELLING PRICE (ASP) TREND OF VNA AND PACS SOLUTIONS,
BY PRODUCT TYPE 59
5.5.2 AVERAGE SELLING PRICE TREND, BY REGION 60
5.6 KEY CONFERENCES AND EVENTS, 2026?2027 60
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 61
5.8 INVESTMENT AND FUNDING SCENARIO 61
5.9 CASE STUDY ANALYSIS 62
5.9.1 AMBRA HEALTH UTILIZED AWS CLOUD SERVICES TO PROPEL WORLDWIDE GROWTH OF ITS MEDICAL IMAGING PLATFORM 62
5.9.2 NHS TRUST ADOPTED INTEGRATION AND INSTANT DATA ACCESS OFFERED
BY SYNAPPS VNA TO ESTABLISH UNIFIED PLATFORM FOR STORING AND MANAGING DICOM IMAGE DATA 63
5.10 IMPACT OF 2025 US TARIFF OVERVIEW 63
5.10.1 INTRODUCTION 63
5.10.2 KEY TARIFF RATES 63
5.10.3 PRICE IMPACT ANALYSIS 64
5.11 IMPACT ON COUNTRY/REGION 64
5.11.1 THE US 64
5.11.2 EUROPE 64
5.11.3 APAC 65
?
5.12 IMPACT ON END USE INDUSTRIES 65
5.13 CONCLUSION 66
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 67
6.1 KEY EMERGING TECHNOLOGIES 67
6.1.1 DICOM (DIGITAL IMAGING AND COMMUNICATIONS IN MEDICINE) 67
6.1.2 ENTERPRISE IMAGING SOLUTIONS 67
6.1.3 CLOUD-BASED STORAGE AND SERVICES 67
6.2 COMPLEMENTARY TECHNOLOGIES 67
6.2.1 IMAGE EXCHANGE NETWORKS 67
6.2.2 DATA ANALYTICS AND BUSINESS INTELLIGENCE 67
6.3 ADJACENT TECHNOLOGIES 68
6.3.1 HEALTH INFORMATION EXCHANGE (HIE) 68
6.4 PATENT ANALYSIS 68
6.4.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 68
6.5 FUTURE APPLICATIONS 70
6.5.1 AI-ENABLED ENTERPRISE DIAGNOSTIC ORCHESTRATION 70
6.5.2 MULTI-SPECIALTY ENTERPRISE IMAGING REPOSITORY 71
6.5.3 IMAGING DATA LAKE FOR CLINICAL RESEARCH AND REAL-WORLD EVIDENCE 71
6.5.4 CLOUD-BASED REGIONAL IMAGE EXCHANGE AND VIRTUAL CARE NETWORKS 71
6.5.5 PERSONALIZED AND LONGITUDINAL IMAGING INTELLIGENCE 72
7 REGULATORY LANDSCAPE 73
7.1 REGIONAL REGULATIONS AND COMPLIANCE 73
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
7.1.2 REGULATIONS 75
7.1.2.1 US 75
7.1.2.2 Europe 75
7.1.2.3 China 76
7.1.2.4 Japan 76
7.1.2.5 India 76
7.1.3 INDUSTRY STANDARDS 76
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 77
8.1 INTRODUCTION 77
8.2 DECISION-MAKING PROCESS 77
8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 77
8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 77
8.3.2 BUYING CRITERIA 78
?
8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES 79
8.5 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 80
8.5.1 UNMET NEEDS 80
8.5.2 END-USER EXPECTATIONS 81
8.6 MARKET PROFITABILITY 82
9 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE 83
9.1 INTRODUCTION 84
9.2 VNA 84
9.2.1 DEPARTMENT VNA 86
9.2.1.1 Phased imaging modernization driving VNA adoption and interoperability growth 86
9.2.2 MULTI-DEPARTMENT VNA 87
9.2.2.1 Cross-department imaging consolidation driving scalable enterprise data platform adoption 87
9.2.3 MULTI-SITE VNA 89
9.2.3.1 Cloud-based multi-site imaging consolidation enabling scalable, centralized care delivery 89
9.3 PACS 90
9.3.1 DEPARTMENT PACS 92
9.3.1.1 Rising imaging volumes and workforce shortages driving
workflow-centric PACS adoption 92
9.3.2 MULTI-DEPARTMENT PACS 93
9.3.2.1 Shared imaging platforms reducing silos and enabling cross-specialty collaboration 93
9.3.3 MULTI-SITE PACS 95
9.3.3.1 Centralized cloud PACS enabling cross-site workload balancing and productivity gains 95
10 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY 97
10.1 INTRODUCTION 98
10.2 CT 98
10.2.1 RAPID RISE IN NEED FOR CT EXAMINATIONS TO SUPPORT MARKET GROWTH 98
10.3 MAMMOGRAPHY 100
10.3.1 RISE IN NUMBER OF MAMMOGRAPHY PROCEDURES TO DRIVE MARKET GROWTH 100
10.4 ULTRASOUND 101
10.4.1 RISING TECHNOLOGICAL ADVANCEMENT IN ULTRASOUND DEVICES TO SUPPORT MARKET GROWTH 101
10.5 MAGNETIC RESONANCE IMAGING (MRI) 103
10.5.1 MRI IS COST-EFFECTIVE AND EASILY AVAILABLE COMPARED TO PET 103
10.6 X-RAY 104
10.6.1 RAPID ADOPTION OF X-RAY IMAGING COMPARED TO OTHER MODALITIES TO BOOST MARKET 104
?
10.7 PET 106
10.7.1 INCREASING USE OF NUCLEAR MEDICINES TO SUPPORT POPULARITY OF PET 106
11 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL 108
11.1 INTRODUCTION 109
11.2 ON-PREMISE MODEL 109
11.2.1 ON-PREMISE DEPLOYMENT MODEL PROVIDES HEALTHCARE ORGANIZATIONS WITH GREAT CONTROL AND SECURITY OVER SENSITIVE PATIENT DATA 109
11.3 CLOUD-BASED MODEL 111
11.3.1 TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTIC IMAGING MODALITIES TO DRIVE CLOUD-BASED MODEL’S POPULARITY 111
11.4 HYBRID MODEL 112
11.4.1 UNIFIED EFFICIENCY FOR OPTIMAL PERFORMANCE TO DRIVE HYBRID VNA AND PACS SOLUTIONS 112
12 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE 114
12.1 INTRODUCTION 115
12.2 INDEPENDENT VENDOR 115
12.2.1 DOMINANCE OF INDEPENDENT VENDORS TO CAPTURE SIGNIFICANT MARKET SHARE 115
12.3 THIRD-PARTY VENDOR 117
12.3.1 NEED FOR INNOVATIVE SOLUTIONS TO FUEL SURGE IN THIRD-PARTY VENDORS’ PRESENCE IN MARKET 117
13 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION 119
13.1 INTRODUCTION 120
13.2 CARDIOLOGY 120
13.2.1 RISING CASES OF CARDIAC DISORDERS TO DRIVE MARKET 120
13.3 ORTHOPEDIC 122
13.3.1 GROWTH IN CASES OF ARTHRITIS TO SUPPORT MARKET GROWTH 122
13.4 ONCOLOGY 123
13.4.1 RISE IN NUMBER OF CANCER CASES TO DRIVE USE OF VNA AND PACS SOLUTIONS FOR ONCOLOGY 123
13.5 NEUROLOGY 125
13.5.1 INCREASING DEMAND FOR ADVANCED NEUROLOGICAL IMAGING TECHNOLOGIES TO SPUR GROWTH 125
13.6 OBSTETRICS & GYNECOLOGY 126
13.6.1 USE OF 3D AND 4D IMAGING FOR MONITORING FETUS GROWTH AND DIAGNOSING HIGH-RISK PREGNANCIES TO DRIVE APPLICATION OF VNA AND PACS SOLUTIONS 126
13.7 OTHER APPLICATIONS 128
?
14 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER 130
14.1 INTRODUCTION 131
14.2 HOSPITALS & CLINICS 131
14.2.1 GROWING NEED TO IMPROVE PROFITABILITY OF HEALTHCARE SERVICES TO DRIVE USE OF HCIT IN HOSPITALS 131
14.3 DIAGNOSTIC CENTERS 133
14.3.1 POPULARITY OF DIAGNOSTIC CENTERS TO PROPEL USE OF VNA AND PACS SOLUTIONS 133
14.4 AMBULATORY SURGERY CENTERS 134
14.4.1 INCREASING NUMBER OF INTERVENTIONAL IMAGING PROCEDURES TO SUPPORT USE OF VNA AND PACS SOLUTIONS IN AMBULATORY SURGERY CENTERS 134
14.5 OTHER END USERS 136
15 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY REGION 138
15.1 INTRODUCTION 139
15.2 NORTH AMERICA 139
15.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 144
15.2.2 US 144
15.2.2.1 Regulatory Interoperability Mandates and Cloud-First Enterprise Imaging Strategies 144
15.2.3 CANADA 148
15.2.3.1 Pan-Canadian Interoperability Drive Opens Enterprise Imaging Investment Pipeline 148
15.3 EUROPE 153
15.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 157
15.3.2 GERMANY 157
15.3.2.1 Hospital Future Act Investment Cycle Accelerates PACS and VNA Modernization 157
15.3.3 UK 160
15.3.3.1 NHS Digital Diagnostic Programme and AI Mandate Catalyze GBP 700M Imaging IT Overhaul 160
15.3.4 FRANCE 165
15.3.4.1 S?gur du Num?rique Imaging Wave Drives RIS-PACS Interoperability at National Scale 165
15.3.5 ITALY 168
15.3.5.1 PNRR-Funded Hospital Modernization Drives PACS Replacement and Digital Imaging Upgrades 168
15.3.6 SPAIN 172
15.3.6.1 National Health System Digitization and Regional Imaging Network Expansion Drive Market Growth 172
15.3.7 REST OF EUROPE 176
?
15.4 ASIA PACIFIC 181
15.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 184
15.4.2 JAPAN 185
15.4.2.1 Aging Society and Society 5.0 Strategy Drive Next-Generation PACS Replacement Cycle 185
15.4.3 CHINA 189
15.4.3.1 Healthy China 2030 and 14th Five-Year Plan Drive National EMR and Imaging Informatization 189
15.4.4 INDIA 194
15.4.4.1 Ayushman Bharat Digital Mission Creates National Imaging Data Infrastructure Demand 194
15.4.5 REST OF ASIA PACIFIC 197
15.5 LATIN AMERICA 202
15.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 205
15.5.2 BRAZIL 206
15.5.2.1 SUS Hospital Modernization and Private Sector AI Imaging Adoption Drive Regional Market Leadership 206
15.5.3 MEXICO 209
15.5.3.1 Private Hospital Expansion and Public Sector Technology Modernization Open PACS Growth Pathway 209
15.5.4 REST OF LATIN AMERICA 213
15.6 MIDDLE EAST & AFRICA 218
15.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 222
15.6.2 GCC COUNTRIES 222
15.6.2.1 Vision 2030 and National Health Digitization Investments Accelerate Smart Hospital Imaging Deployments 222
15.6.3 REST OF MIDDLE EAST & AFRICA 226
16 COMPETITIVE LANDSCAPE 231
16.1 OVERVIEW 231
16.2 KEY PLAYERS’ STRATEGIES/RIGHT TO WIN 231
16.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET 232
16.3 REVENUE SHARE ANALYSIS 234
16.4 MARKET SHARE ANALYSIS, 2025 234
16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 237
16.5.1 STARS 237
16.5.2 EMERGING LEADERS 237
16.5.3 PERVASIVE PLAYERS 237
16.5.4 PARTICIPANTS 238
16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 239
16.5.5.1 Company footprint 239
16.5.5.2 Product footprint 240
16.5.5.3 Deployment footprint 240
16.5.5.4 End user footprint 241
16.5.5.5 Regional footprint 242
16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 243
16.6.1 PROGRESSIVE COMPANIES 243
16.6.2 RESPONSIVE COMPANIES 243
16.6.3 DYNAMIC COMPANIES 243
16.6.4 STARTING BLOCKS 243
16.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 245
16.6.5.1 Detailed list of key startups/SMEs 245
16.7 COMPANY VALUATION AND FINANCIAL METRICS 246
16.8 BRAND/SOFTWARE COMPARISON 247
16.9 COMPETITIVE SCENARIO 248
16.9.1 PRODUCT LAUNCHES & UPGRADES 248
16.9.2 DEALS 249
16.9.3 OTHER DEVELOPMENTS 250
17 COMPANY PROFILES 251
17.1 KEY COMPANIES 251
17.1.1 AGFA-GEVAERT GROUP 251
17.1.1.1 Business overview 251
17.1.1.2 Solutions offered 252
17.1.1.3 Recent developments 253
17.1.1.3.1 Deals 253
17.1.1.4 MnM view 254
17.1.1.4.1 Right to win 254
17.1.1.4.2 Strategic choices 254
17.1.1.4.3 Weaknesses & competitive threats 254
17.1.2 FUJIFILM HOLDINGS CORPORATION 255
17.1.2.1 Business overview 255
17.1.2.2 Solutions offered 256
17.1.2.3 Recent developments 257
17.1.2.3.1 Deals 257
17.1.2.3.2 Other developments 258
17.1.2.4 MnM view 258
17.1.2.4.1 Right to win 258
17.1.2.4.2 Strategic choices 258
17.1.2.4.3 Weaknesses & competitive threats 258
?
17.1.3 SECTRA AB 259
17.1.3.1 Business overview 259
17.1.3.2 Solutions offered 260
17.1.3.3 MnM view 261
17.1.3.3.1 Right to win 261
17.1.3.3.2 Strategic choices 261
17.1.3.3.3 Weaknesses & competitive threats 262
17.1.4 GE HEALTHCARE 263
17.1.4.1 Business overview 263
17.1.4.2 Solutions offered 264
17.1.4.3 Recent developments 265
17.1.4.3.1 Product launches 265
17.1.4.3.2 Deals 266
17.1.4.4 MnM view 266
17.1.4.4.1 Right to win 266
17.1.4.4.2 Strategic choices 267
17.1.4.4.3 Weaknesses & competitive threats 267
17.1.5 MERATIVE 268
17.1.5.1 Business overview 268
17.1.5.2 Solutions offered 268
17.1.5.3 Recent developments 269
17.1.5.3.1 Deals 269
17.1.5.4 MnM view 270
17.1.5.4.1 Key strengths 270
17.1.5.4.2 Strategic choices 270
17.1.5.4.3 Weaknesses & competitive threats 270
17.1.6 KONINKLIJKE PHILIPS N.V. 271
17.1.6.1 Business overview 271
17.1.6.2 Solutions offered 272
17.1.6.3 Recent developments 273
17.1.6.3.1 Product launches 273
17.1.6.3.2 Deals 274
17.1.7 CANON MEDICAL SYSTEMS CORPORATION 275
17.1.7.1 Business overview 275
17.1.7.2 Solutions offered 276
17.1.7.3 Recent developments 277
17.1.7.3.1 Deals 277
17.1.8 PAXERAHEALTH 278
17.1.8.1 Business overview 278
17.1.8.2 Solutions offered 278
?
17.1.9 NOVARAD CORPORATION 280
17.1.9.1 Business overview 280
17.1.9.2 Solutions offered 280
17.1.10 HYLAND SOFTWARE, INC. 282
17.1.10.1 Business overview 282
17.1.10.2 Solutions offered 282
17.1.10.3 Recent developments 283
17.1.10.3.1 Deals 283
17.1.11 SIEMENS HEALTHCARE LIMITED 284
17.1.11.1 Business overview 284
17.1.11.2 Solutions offered 285
17.1.11.3 Recent developments 286
17.1.11.3.1 Deals 286
17.1.12 BRIDGEHEAD SOFTWARE LTD. 287
17.1.12.1 Business overview 287
17.1.12.2 Solutions offered 287
17.1.13 CANOPY PARTNERS 288
17.1.13.1 Business overview 288
17.1.13.2 Solutions offered 288
17.1.14 CRELIOHEALTH INC. 289
17.1.14.1 Business overview 289
17.1.14.2 Solutions offered 289
17.1.15 ASPYRA, LLC 290
17.1.15.1 Business overview 290
17.1.15.2 Solutions offered 290
17.1.16 POSTDICOM 292
17.1.16.1 Business overview 292
17.1.16.2 Solutions offered 292
17.1.17 MEDICASOFT 294
17.1.17.1 Business overview 294
17.1.17.2 Solutions offered 294
17.1.18 ESAOTE SPA 295
17.1.18.1 Business overview 295
17.1.18.2 Solutions offered 295
17.1.18.3 Recent developments 296
17.1.18.3.1 Product launches 296
17.1.19 VISUS HEALTH IT GMBH 297
17.1.19.1 Business overview 297
17.1.19.2 Solutions offered 297
?
17.2 OTHER PLAYERS 298
17.2.1 ADVAHEALTH SOLUTIONS 298
17.2.2 SOFTTEAM SOLUTIONS PVT. LTD. 299
17.2.3 ARO SYSTEMS 299
17.2.4 CENTRAL DATA NETWORKS 300
17.2.5 ONEPACS 300
17.2.6 DEDALUS SPA. 301
18 RESEARCH METHODOLOGY 302
18.1 RESEARCH APPROACH 302
18.1.1 SECONDARY RESEARCH 302
18.1.1.1 Key data from secondary sources 303
18.1.2 PRIMARY RESEARCH 304
18.1.2.1 Primary sources 304
18.1.2.2 Key data from primary sources 305
18.1.2.3 Breakdown of primary interviews 306
18.1.2.4 Insights from primary experts 306
18.2 RESEARCH METHODOLOGY DESIGN 307
18.3 MARKET SIZE ESTIMATION 308
18.4 DATA TRIANGULATION 313
18.5 RESEARCH ASSUMPTIONS 314
18.6 RESEARCH LIMITATIONS 314
18.6.1 METHODOLOGY-RELATED 314
18.6.2 SCOPE-RELATED 315
18.7 RISK ASSESSMENT 315
19 APPENDIX 316
19.1 DISCUSSION GUIDE 316
19.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 322
19.3 CUSTOMIZATION OPTIONS 324
19.4 RELATED REPORTS 324
19.5 AUTHOR DETAILS 325

ページTOPに戻る

List of Tables/Graphs

TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 32
TABLE 2 IMPACT OF PORTER’S FIVE FORCES ON VENDOR NEUTRAL ARCHIVE (VNA)
& PACS MARKET 53
TABLE 3 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: ROLE IN ECOSYSTEM 58
TABLE 4 AVERAGE SELLING PRICE OF PACS SOLUTIONS, BY PRODUCT TYPE (USD) 59
TABLE 5 AVERAGE SELLING PRICE OF VNA SOLUTIONS, BY PRODUCT TYPE (USD) 59
TABLE 6 KEY CONFERENCES AND EVENTS, 2026?2027 60
TABLE 7 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR AI IN TELEHEALTH
& TELEMEDICINE 68
TABLE 8 LIST OF PATENTS/PATENT APPLICATIONS, 2015?2025 70
TABLE 9 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 11 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 12 ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF FOUR END USERS 78
TABLE 14 KEY BUYING CRITERIA FOR FOUR END USERS 79
TABLE 15 UNMET NEEDS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET 80
TABLE 16 END-USER EXPECTATIONS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET 81
TABLE 17 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE,
2024?2031 (USD MILLION) 84
TABLE 18 VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE,
2024?2031 (USD MILLION) 85
TABLE 19 VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 85
TABLE 20 DEPARTMENT VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 87
TABLE 21 MULTI-DEPARTMENT VENDOR NEUTRAL ARCHIVE (VNA) MARKET,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 88
TABLE 22 MULTI-SITE VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 90
TABLE 23 PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 91
TABLE 24 PACS MARKET, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 91
TABLE 25 DEPARTMENT PACS MARKET, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 93
TABLE 26 MULTI-DEPARTMENT PACS MARKET, BY COUNTRY/REGION,
2024?2031 (USD MILLION) 94
TABLE 27 MULTI-SITE PACS MARKET, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 96
TABLE 28 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY,
2024?2031 (USD MILLION) 98
TABLE 29 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR CT, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 99
TABLE 30 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR MAMMOGRAPHY,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 101
TABLE 31 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR ULTRASOUND,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 102
TABLE 32 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), BY COUNTRY/REGION, 2024?2031 (USD MILLION) 104
TABLE 33 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR X-RAY,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 105
TABLE 34 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR PET,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 107
TABLE 35 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024?2031 (USD MILLION) 109
TABLE 36 ON-PREMISE VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 110
TABLE 37 CLOUD-BASED VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 112
TABLE 38 HYBRID VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 113
TABLE 39 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE,
2024?2031 (USD MILLION) 115
TABLE 40 INDEPENDENT VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 116
TABLE 41 THIRD-PARTY VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 118
TABLE 42 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 120
TABLE 43 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR CARDIOLOGY APPLICATIONS, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 121
TABLE 44 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 123
TABLE 45 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR ONCOLOGY APPLICATIONS, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 124
TABLE 46 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR NEUROLOGY APPLICATIONS, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 126
TABLE 47 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR OBSTETRICS AND GYNECOLOGY APPLICATIONS, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 127
TABLE 48 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 129
TABLE 49 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER,
2024?2031 (USD MILLION) 131
TABLE 50 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 132
TABLE 51 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR DIAGNOSTIC CENTERS,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 134
TABLE 52 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY/REGION, 2024?2031 (USD MILLION) 135
TABLE 53 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET FOR OTHER END USERS,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 137
TABLE 54 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY REGION,
2024?2031 (USD MILLION) 139
TABLE 55 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 140
TABLE 56 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY PRODUCT TYPE, 2024?2031 (USD MILLION) 141
TABLE 57 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 141
TABLE 58 NORTH AMERICA: PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 141
TABLE 59 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY MODALITY, 2024?2031 (USD MILLION) 142
TABLE 60 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY DEPLOYMENT MODEL, 2024?2031 (USD MILLION) 142
TABLE 61 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY VENDOR TYPE, 2024?2031 (USD MILLION) 143
TABLE 62 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY APPLICATION, 2024?2031 (USD MILLION) 143
TABLE 63 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY END USER, 2024?2031 (USD MILLION) 144
TABLE 64 US: KEY MACRO INDICATORS 145
TABLE 65 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 146
TABLE 66 US: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE,
2024?2031 (USD MILLION) 146
TABLE 67 US: PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 146
TABLE 68 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY,
2024?2031 (USD MILLION) 147
TABLE 69 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024?2031 (USD MILLION) 147
TABLE 70 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE,
2024?2031 (USD MILLION) 147
TABLE 71 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 148
TABLE 72 US: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER,
2024?2031 (USD MILLION) 148
TABLE 73 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 149
TABLE 74 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE,
2024?2031 (USD MILLION) 149
TABLE 75 CANADA: PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 150
TABLE 76 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024?2031 (USD MILLION) 150
TABLE 77 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY DEPLOYMENT MODEL, 2024?2031 (USD MILLION) 151
TABLE 78 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024?2031 (USD MILLION) 151
TABLE 79 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 152
TABLE 80 CANADA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024?2031 (USD MILLION) 152
TABLE 81 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 153
TABLE 82 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 153
TABLE 83 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE,
2024?2031 (USD MILLION) 154
TABLE 84 EUROPE: PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 154
TABLE 85 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024?2031 (USD MILLION) 154
TABLE 86 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY DEPLOYMENT MODEL, 2024?2031 (USD MILLION) 155
TABLE 87 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024?2031 (USD MILLION) 155
TABLE 88 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 156
TABLE 89 EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024?2031 (USD MILLION) 156
TABLE 90 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 158
TABLE 91 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 158
TABLE 92 GERMANY: PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 158
TABLE 93 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024?2031 (USD MILLION) 159
TABLE 94 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY DEPLOYMENT MODEL, 2024?2031 (USD MILLION) 159
TABLE 95 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024?2031 (USD MILLION) 159
TABLE 96 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 160
TABLE 97 GERMANY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024?2031 (USD MILLION) 160
TABLE 98 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 162
TABLE 99 UK: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE,
2024?2031 (USD MILLION) 162
TABLE 100 UK: PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 162
TABLE 101 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY,
2024?2031 (USD MILLION) 163
TABLE 102 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024?2031 (USD MILLION) 163
TABLE 103 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE,
2024?2031 (USD MILLION) 163
TABLE 104 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 164
TABLE 105 UK: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER,
2024?2031 (USD MILLION) 164
TABLE 106 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 165
TABLE 107 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE,
2024?2031 (USD MILLION) 166
TABLE 108 FRANCE: PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 166
TABLE 109 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024?2031 (USD MILLION) 166
TABLE 110 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY DEPLOYMENT MODEL, 2024?2031 (USD MILLION) 167
TABLE 111 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024?2031 (USD MILLION) 167
TABLE 112 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 168
TABLE 113 FRANCE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024?2031 (USD MILLION) 168
TABLE 114 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 169
TABLE 115 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE,
2024?2031 (USD MILLION) 169
TABLE 116 ITALY: PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 170
TABLE 117 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY,
2024?2031 (USD MILLION) 170
TABLE 118 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY DEPLOYMENT MODEL, 2024?2031 (USD MILLION) 171
TABLE 119 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024?2031 (USD MILLION) 171
TABLE 120 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 172
TABLE 121 ITALY: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER,
2024?2031 (USD MILLION) 172
TABLE 122 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 173
TABLE 123 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE,
2024?2031 (USD MILLION) 173
TABLE 124 SPAIN: PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 174
TABLE 125 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY,
2024?2031 (USD MILLION) 174
TABLE 126 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY DEPLOYMENT MODEL, 2024?2031 (USD MILLION) 175
TABLE 127 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024?2031 (USD MILLION) 175
TABLE 128 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 176
TABLE 129 SPAIN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER,
2024?2031 (USD MILLION) 176
TABLE 130 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY PRODUCT TYPE, 2024?2031 (USD MILLION) 177
TABLE 131 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 177
TABLE 132 REST OF EUROPE: PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 178
TABLE 133 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY MODALITY, 2024?2031 (USD MILLION) 178
TABLE 134 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY DEPLOYMENT MODEL, 2024?2031 (USD MILLION) 179
TABLE 135 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY VENDOR TYPE, 2024?2031 (USD MILLION) 179
TABLE 136 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY APPLICATION, 2024?2031 (USD MILLION) 180
TABLE 137 REST OF EUROPE: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY END USER, 2024?2031 (USD MILLION) 180
TABLE 138 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 181
TABLE 139 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY PRODUCT TYPE, 2024?2031 (USD MILLION) 181
TABLE 140 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 182
TABLE 141 ASIA PACIFIC: PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 182
TABLE 142 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY MODALITY, 2024?2031 (USD MILLION) 182
TABLE 143 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY DEPLOYMENT MODEL, 2024?2031 (USD MILLION) 183
TABLE 144 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY VENDOR TYPE, 2024?2031 (USD MILLION) 183
TABLE 145 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY APPLICATION, 2024?2031 (USD MILLION) 184
TABLE 146 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024?2031 (USD MILLION) 184
TABLE 147 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 186
TABLE 148 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE,
2024?2031 (USD MILLION) 186
TABLE 149 JAPAN: PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 187
TABLE 150 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY,
2024?2031 (USD MILLION) 187
TABLE 151 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY DEPLOYMENT MODEL, 2024?2031 (USD MILLION) 188
TABLE 152 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024?2031 (USD MILLION) 188
TABLE 153 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 189
TABLE 154 JAPAN: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER,
2024?2031 (USD MILLION) 189
TABLE 155 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 190
TABLE 156 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE,
2024?2031 (USD MILLION) 190
TABLE 157 CHINA: PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 191
TABLE 158 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY,
2024?2031 (USD MILLION) 191
TABLE 159 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY DEPLOYMENT MODEL, 2024?2031 (USD MILLION) 192
TABLE 160 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024?2031 (USD MILLION) 192
TABLE 161 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 193
TABLE 162 CHINA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER,
2024?2031 (USD MILLION) 193
TABLE 163 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 194
TABLE 164 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE,
2024?2031 (USD MILLION) 195
TABLE 165 INDIA: PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 195
TABLE 166 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY,
2024?2031 (USD MILLION) 195
TABLE 167 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY DEPLOYMENT MODEL, 2024?2031 (USD MILLION) 196
TABLE 168 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024?2031 (USD MILLION) 196
TABLE 169 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 197
TABLE 170 INDIA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER,
2024?2031 (USD MILLION) 197
TABLE 171 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY PRODUCT TYPE, 2024?2031 (USD MILLION) 198
TABLE 172 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) MARKET,
BY PRODUCT TYPE, 2024?2031 (USD MILLION) 198
TABLE 173 REST OF ASIA PACIFIC: PACS MARKET, BY PRODUCT TYPE,
2024?2031 (USD MILLION) 199
TABLE 174 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY MODALITY, 2024?2031 (USD MILLION) 199
TABLE 175 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY DEPLOYMENT MODEL, 2024?2031 (USD MILLION) 200
TABLE 176 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY VENDOR TYPE, 2024?2031 (USD MILLION) 200
TABLE 177 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY APPLICATION, 2024?2031 (USD MILLION) 201
TABLE 178 REST OF ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY END USER, 2024?2031 (USD MILLION) 201
TABLE 179 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 202
TABLE 180 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY PRODUCT TYPE, 2024?2031 (USD MILLION) 202
TABLE 181 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 203
TABLE 182 LATIN AMERICA: PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 203
TABLE 183 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY MODALITY, 2024?2031 (USD MILLION) 204
TABLE 184 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY DEPLOYMENT MODEL, 2024?2031 (USD MILLION) 204
TABLE 185 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY VENDOR TYPE, 2024?2031 (USD MILLION) 204
TABLE 186 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY APPLICATION, 2024?2031 (USD MILLION) 205
TABLE 187 LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY END USER, 2024?2031 (USD MILLION) 205
TABLE 188 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 206
TABLE 189 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE,
2024?2031 (USD MILLION) 207
TABLE 190 BRAZIL: PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 207
TABLE 191 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY,
2024?2031 (USD MILLION) 208
TABLE 192 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY DEPLOYMENT MODEL, 2024?2031 (USD MILLION) 208
TABLE 193 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024?2031 (USD MILLION) 208
TABLE 194 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 209
TABLE 195 BRAZIL: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER,
2024?2031 (USD MILLION) 209
TABLE 196 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 210
TABLE 197 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE,
2024?2031 (USD MILLION) 210
TABLE 198 MEXICO: PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 211
TABLE 199 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024?2031 (USD MILLION) 211
TABLE 200 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY DEPLOYMENT MODEL, 2024?2031 (USD MILLION) 212
TABLE 201 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024?2031 (USD MILLION) 212
TABLE 202 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 213
TABLE 203 MEXICO: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024?2031 (USD MILLION) 213
TABLE 204 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY PRODUCT TYPE, 2024?2031 (USD MILLION) 214
TABLE 205 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) MARKET,
BY PRODUCT TYPE, 2024?2031 (USD MILLION) 214
TABLE 206 REST OF LATIN AMERICA: PACS MARKET, BY PRODUCT TYPE,
2024?2031 (USD MILLION) 215
TABLE 207 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY MODALITY, 2024?2031 (USD MILLION) 215
TABLE 208 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY DEPLOYMENT MODEL, 2024?2031 (USD MILLION) 216
TABLE 209 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY VENDOR TYPE, 2024?2031 (USD MILLION) 216
TABLE 210 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY APPLICATION, 2024?2031 (USD MILLION) 217
TABLE 211 REST OF LATIN AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY END USER, 2024?2031 (USD MILLION) 217
TABLE 212 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY COUNTRY/REGION, 2024?2031 (USD MILLION) 218
TABLE 213 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY PRODUCT TYPE, 2024?2031 (USD MILLION) 218
TABLE 214 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) MARKET,
BY PRODUCT TYPE, 2024?2031 (USD MILLION) 219
TABLE 215 MIDDLE EAST & AFRICA: PACS MARKET, BY PRODUCT TYPE,
2024?2031 (USD MILLION) 219
TABLE 216 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY MODALITY, 2024?2031 (USD MILLION) 220
TABLE 217 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY DEPLOYMENT MODEL, 2024?2031 (USD MILLION) 220
TABLE 218 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY VENDOR TYPE, 2024?2031 (USD MILLION) 221
TABLE 219 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY APPLICATION, 2024?2031 (USD MILLION) 221
TABLE 220 MIDDLE EAST & AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY END USER, 2024?2031 (USD MILLION) 222
TABLE 221 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY PRODUCT TYPE, 2024?2031 (USD MILLION) 223
TABLE 222 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 223
TABLE 223 GCC COUNTRIES: PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 224
TABLE 224 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY MODALITY, 2024?2031 (USD MILLION) 224
TABLE 225 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY DEPLOYMENT MODEL, 2024?2031 (USD MILLION) 225
TABLE 226 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY VENDOR TYPE, 2024?2031 (USD MILLION) 225
TABLE 227 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY APPLICATION, 2024?2031 (USD MILLION) 226
TABLE 228 GCC COUNTRIES: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
BY END USER, 2024?2031 (USD MILLION) 226
TABLE 229 REST OF MIDDLE EAST AND AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 227
TABLE 230 REST OF MIDDLE EAST AND AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) MARKET, BY PRODUCT TYPE, 2024?2031 (USD MILLION) 227
TABLE 231 REST OF MIDDLE EAST AND AFRICA: PACS MARKET, BY PRODUCT TYPE,
2024?2031 (USD MILLION) 228
TABLE 232 REST OF MIDDLE EAST AND AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY MODALITY, 2024?2031 (USD MILLION) 228
TABLE 233 REST OF MIDDLE EAST AND AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY DEPLOYMENT MODEL, 2024?2031 (USD MILLION) 229
TABLE 234 REST OF MIDDLE EAST AND AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY VENDOR TYPE, 2024?2031 (USD MILLION) 229
TABLE 235 REST OF MIDDLE EAST AND AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 230
TABLE 236 REST OF MIDDLE EAST AND AFRICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, BY END USER, 2024?2031 (USD MILLION) 230
TABLE 237 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, JANUARY 2023?APRIL 2026 232
TABLE 238 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DEGREE OF COMPETITION 235
TABLE 239 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: PRODUCT FOOTPRINT, 2025 240
TABLE 240 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET:
DEPLOYMENT FOOTPRINT, 2025 240
TABLE 241 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: END USER FOOTPRINT, 2025 241
TABLE 242 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: REGIONAL FOOTPRINT, 2025 242
TABLE 243 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2025 245
TABLE 244 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2025 245
TABLE 245 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: PRODUCT LAUNCHES & UPGRADES, JANUARY 2023?APRIL 2026 248
TABLE 246 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DEALS,
JANUARY 2023?APRIL 2026 249
TABLE 247 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: OTHER DEVELOPMENTS, JANUARY 2023?APRIL 2026 250
TABLE 248 AGFA-GEVAERT GROUP: BUSINESS OVERVIEW 251
TABLE 249 AGFA-GEVAERT GROUP: SOLUTIONS OFFERED 252
TABLE 250 AGFA-GEVAERT GROUP: DEALS 253
TABLE 251 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW 255
TABLE 252 FUJIFILM HOLDINGS CORPORATION: SOLUTIONS OFFERED 256
TABLE 253 FUJIFILM HOLDINGS CORPORATION: DEALS 257
TABLE 254 FUJIFILM HOLDINGS CORPORATION: OTHER DEVELOPMENTS 258
TABLE 255 SECTRA AB: BUSINESS OVERVIEW 259
TABLE 256 SECTRA AB: SOLUTIONS OFFERED 260
TABLE 257 GE HEALTHCARE: BUSINESS OVERVIEW 263
TABLE 258 GE HEALTHCARE: SOLUTIONS OFFERED 264
TABLE 259 GE HEALTHCARE: PRODUCTS LAUNCHES 265
TABLE 260 GE HEALTHCARE: DEALS 266
TABLE 261 MERATIVE: BUSINESS OVERVIEW 268
TABLE 262 MERATIVE: SOLUTIONS OFFERED 268
TABLE 263 MERATIVE: DEALS 269
TABLE 264 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 271
TABLE 265 KONINKLIJKE PHILIPS N.V.: SOLUTIONS OFFERED 272
TABLE 266 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES 273
TABLE 267 KONINKLIJKE PHILIPS N.V.: DEALS 274
TABLE 268 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW 275
TABLE 269 CANON MEDICAL SYSTEMS CORPORATION: SOLUTIONS OFFERED 276
TABLE 270 CANON MEDICAL SYSTEMS CORPORATION: DEALS 277
TABLE 271 PAXERAHEALTH: BUSINESS OVERVIEW 278
TABLE 272 PAXERAHEALTH: SOLUTIONS OFFERED 278
TABLE 273 NOVARAD CORPORATION: BUSINESS OVERVIEW 280
TABLE 274 NOVARAD CORPORATION: SOLUTIONS OFFERED 280
TABLE 275 HYLAND SOFTWARE, INC.: BUSINESS OVERVIEW 282
TABLE 276 HYLAND SOFTWARE, INC.: SOLUTIONS OFFERED 282
TABLE 277 HYLAND SOFTWARE, INC.: DEALS 283
TABLE 278 SIEMENS HEALTHCARE LIMITED: BUSINESS OVERVIEW 284
TABLE 279 SIEMENS HEALTHCARE LIMITED: SOLUTIONS OFFERED 285
TABLE 280 SIEMENS HEALTHCARE LIMITED: DEALS 286
TABLE 281 BRIDGEHEAD SOFTWARE LTD.: BUSINESS OVERVIEW 287
TABLE 282 BRIDGEHEAD SOFTWARE LTD.: SOLUTIONS OFFERED 287
TABLE 283 CANOPY PARTNERS: BUSINESS OVERVIEW 288
TABLE 284 CANOPY PARTNERS: SOLUTIONS OFFERED 288
TABLE 285 CRELIOHEALTH INC.: BUSINESS OVERVIEW 289
TABLE 286 CRELIOHEALTH INC.: SOLUTIONS OFFERED 289
TABLE 287 ASPYRA, LLC: BUSINESS OVERVIEW 290
TABLE 288 ASPYRA, LLC: SOLUTIONS OFFERED 290
TABLE 289 POSTDICOM: BUSINESS OVERVIEW 292
TABLE 290 POSTDICOM: SOLUTIONS OFFERED 292
TABLE 291 MEDICASOFT: BUSINESS OVERVIEW 294
TABLE 292 MEDICASOFT: SOLUTIONS OFFERED 294
TABLE 293 ESAOTE SPA.: BUSINESS OVERVIEW 295
TABLE 294 ESAOTE SPA: SOLUTIONS OFFERED 295
TABLE 295 ESAOTE SPA: PRODUCT LAUNCHES 296
TABLE 296 VISUS HEALTH IT GMBH: BUSINESS OVERVIEW 297
TABLE 297 VISUS HEALTH IT GMBH: SOLUTIONS OFFERED 297FIGURE 1 STUDY YEARS CONSIDERED 32
FIGURE 2 MARKET SCENARIO 34
FIGURE 3 GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET,
2024?2031 USD MILLION) 35
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET 35
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET 36
FIGURE 6 HIGH-GROWTH SEGMENTS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET 37
FIGURE 7 ASIA PACIFIC TO BE FASTEST-GROWING REGION DURING FORECAST PERIOD 38
FIGURE 8 EXPANSION OF ENTERPRISE IMAGING & MULTI-SITE HEALTHCARE NETWORKS FUELING DEMAND IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET 39
FIGURE 9 HOSPITALS & END USERS AND US ACCOUNTED FOR LARGEST RESPECTIVE SHARES IN 2025 40
FIGURE 10 INDIA TO EXHIBIT FASTEST GROWTH DURING FORECAST PERIOD 41
FIGURE 11 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 42
FIGURE 12 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: PORTER’S FIVE FORCES ANALYSIS 52
FIGURE 13 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: VALUE CHAIN ANALYSIS 55
FIGURE 14 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: ECOSYSTEM MAPPING 57
FIGURE 15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 61
FIGURE 16 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: INVESTMENT AND FUNDING SCENARIO, 2022?2025 (USD MILLION) 62
FIGURE 17 JURISDICTION AND TOP APPLICANT ANALYSIS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, JANUARY 2022?MAY 2025 68
FIGURE 18 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR VNA AND PACS, JANUARY 2015 TO MAY 2025 69
FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF FOUR END USERS 78
FIGURE 20 KEY BUYING CRITERIA FOR FOUR END USERS 79
FIGURE 21 NORTH AMERICA: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET SNAPSHOT 140
FIGURE 22 UK: COUNT OF DIAGNOSTIC IMAGING ACTIVITY ON NHS PATIENTS, JANUARY 2022?JANUARY 2023 (MILLION) 161
FIGURE 23 ASIA PACIFIC: VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET SNAPSHOT 185
FIGURE 24 REVENUE ANALYSIS OF KEY PLAYERS IN VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET, 2021?2025 (USD MILLION) 234
FIGURE 25 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: MARKET SHARE ANALYSIS (2025) 235
FIGURE 26 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 238
FIGURE 27 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: COMPANY FOOTPRINT, 2025 239
FIGURE 28 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 244
FIGURE 29 EV/EBITDA OF KEY VENDORS, 2026 246
FIGURE 30 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF VNA AND PACS VENDORS, 2026 246
FIGURE 31 VENDOR NEUTRAL ARCHIVE (VNA) & PACS MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS 247
FIGURE 32 AGFA-GEVAERT GROUP: COMPANY SNAPSHOT 252
FIGURE 33 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT 256
FIGURE 34 SECTRA AB: COMPANY SNAPSHOT 260
FIGURE 35 GE HEALTHCARE: COMPANY SNAPSHOT 264
FIGURE 36 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 272
FIGURE 37 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT 276
FIGURE 38 SIEMENS HEALTHCARE LIMITED: COMPANY SNAPSHOT 285
FIGURE 39 RESEARCH DESIGN 302
FIGURE 40 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 307
FIGURE 41 BOTTOM-UP APPROACH 308
FIGURE 42 TOP-DOWN APPROACH 309
FIGURE 43 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 310
FIGURE 44 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 311
FIGURE 45 DATA TRIANGULATION 313